{
    "root": "5f580130-9b4a-4c37-80b1-734baabb529b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Nabumetone",
    "value": "20250327",
    "ingredients": [
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "POLYETHYLENE GLYCOL 400",
            "code": "B697894SGQ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "NABUMETONE",
            "code": "LW0TIW155Z",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7443"
        }
    ],
    "indications": {
        "text": "carefully consider potential benefits risks nabumetone tablets , usp treatment options deciding nabumetone tablets . lowest effective dose shortest duration consistent individual patient treatment goals ( ) . nabumetone tablets , usp indicated relief signs symptoms osteoarthritis rheumatoid arthritis .",
        "doid_entities": [
            {
                "text": "osteoarthritis (DOID:8398)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8398"
            },
            {
                "text": "rheumatoid arthritis (DOID:7148)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7148"
            },
            {
                "text": "arthritis (DOID:848)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_848"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "carefully consider potential benefits risks nabumetone tablets treatment options deciding nabumetone tablets . lowest effective dose shortest duration consistent individual patient treatment goals ( ) . observing response initial therapy nabumetone tablets , dose frequency adjusted suit individual patient \u2019 needs . osteoarthritis rheumatoid arthritis : recommended starting dose 1,000 mg taken single dose without food . patients may obtain symptomatic relief 1,500 mg 2,000 mg per day . nabumetone given either single twice-daily dose . dosages greater 2,000 mg per day studied . lowest effective dose used chronic treatment ( , renal effects ) . patients weighing 50 kg may less likely require dosages beyond 1,000 mg ; therefore , observing response initial therapy , dose adjusted meet individual patients \u2019 requirements .",
        "doid_entities": [
            {
                "text": "osteoarthritis (DOID:8398)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8398"
            },
            {
                "text": "rheumatoid arthritis (DOID:7148)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7148"
            },
            {
                "text": "arthritis (DOID:848)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_848"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "nabumetone tablets , usp : nabumetone tablets usp , 750 mg white colored , oval shaped , biconvex , film coated tablets , debossed \u2018 sg \u2019 one side \u2018 466 \u2019 side . bottles 100 ndc 63629-8510-1 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) ; excursions permitted 15\u00b0 30\u00b0c ( 59\u00b0 86\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp , child-resistant closure ( required ) . repackaged/relabeled : bryant ranch prepack , inc.burbank , ca 91504",
    "adverseReactions": "nabumetone tablets contraindicated patients known hypersensitivity nabumetone excipients . nabumetone tablets given patients experienced asthma , urticaria , allergic-type taking aspirin nsaids . severe , rarely fatal , anaphylactic-like nsaids reported patients ( , anaphylactoid , , general , preexisting asthma ) . nabumetone tablets contraindicated setting coronary artery bypass graft ( cabg ) surgery [ ] .",
    "indications_original": "Carefully consider the potential benefits and risks of nabumetone tablets, USP and other treatment options before deciding to use nabumetone tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see \n       \n \n  \n       \n \n  \n       \n \n  \n                        WARNINGS\n                     ).\n      \n\n \n      \n\n \n      \n\n \n                  Nabumetone tablets, USP are indicated for relief of signs and symptoms of osteoarthritis and rheumatoid arthritis.",
    "contraindications_original": "Carefully consider the potential benefits and risks of nabumetone tablets and other treatment options before deciding to use nabumetone tablets. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see \n                        WARNINGS\n                     ).\n                  After observing the response to initial therapy with nabumetone tablets, the dose and frequency should be adjusted to suit an individual patient\u2019s needs.\n                  \n                     Osteoarthritis and Rheumatoid Arthritis: The recommended starting dose is 1,000 mg taken as a single dose with or without food. Some patients may obtain more symptomatic relief from 1,500 mg to 2,000 mg per day. Nabumetone can be given in either a single or twice-daily dose. Dosages greater than 2,000 mg per day have not been studied. The lowest effective dose should be used for chronic treatment (see \n                        WARNINGS, Renal Effects\n                     ). Patients weighing under 50 kg may be less likely to require dosages beyond 1,000 mg; therefore, after observing the response to initial therapy, the dose should be adjusted to meet individual patients\u2019 requirements.",
    "warningsAndPrecautions_original": "Nabumetone Tablets, USP:\n                  Nabumetone tablets USP, 750 mg are white colored, oval shaped, biconvex, film coated tablets, debossed with \u2018SG\u2019 on one side \u2018466\u2019 on other side.\n                  \n                     \n                        Bottles of 100 NDC\u00a063629-8510-1\n                     \n                  \n                  \n                     Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F); excursions permitted to 15\u00b0 to 30\u00b0C (59\u00b0 to 86\u00b0F) [see USP Controlled Room Temperature].\n                  \n                  Dispense in tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions_original": "Nabumetone tablets are contraindicated in patients with known hypersensitivity to nabumetone or its excipients.\n                  Nabumetone tablets should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients (see \n       \n \n  \n       \n \n  \n       \n \n  \n                        WARNINGS, \n        \n  \n   \n        \n  \n   \n        \n  \n   Anaphylactoid Reactions\n                     , and \n       \n \n  \n       \n \n  \n       \n \n  \n                        PRECAUTIONS, \n        \n  \n   \n        \n  \n   \n        \n  \n   General, \n        \n  \n   \n        \n  \n   \n        \n  \n   Preexisting Asthma\n                     ).\n      \n\n \n      \n\n \n      \n\n \n                  Nabumetone tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery [see \n       \n \n  \n       \n \n  \n       \n \n  \n                        Warnings\n                     ].",
    "drug": [
        {
            "name": "Nabumetone",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_7443"
        }
    ]
}